Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.
Aurora Cannabis (TSX:ACB) remains unprofitable, but has managed to reduce its losses at an impressive rate of 61.2% per year ...
Aurora Cannabis: Medical Sales Boom Worldwide, Cash Flow to Swing Positive – Quarterly Update Report
Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by ...
Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.
Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net ...
Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...
Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth ...
It’s been a tough few months for Aurora Cannabis (TSX:ACB)(NYSE:ACB) investors. After reaching a peak closing price of $13.26 in April, the stock has been on a gradual but noticeable downtrend, ...
Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good investment right now? Aurora Cannabis produces and sells a variety of cannabis ...
EDMONTON, AB, July 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated ...
Announces today the launch of the company's first German-cultivated medical cannabis product, under ... Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results